Used in research for treating solid tumors, particularly non-small cell lung cancer and breast cancer. It works by inhibiting PI3Kα and PI3Kδ, key proteins involved in cancer cell growth and survival. Shows potential in combination therapies to enhance anti-tumor effects and overcome resistance. Currently in clinical development for evaluating safety and efficacy in humans.